Prime Therapeutics names Manmohan Mahajan chief financial officer
Image File
Original HTML

EAGAN, Minn., Sept. 10, 2026 /PRNewswire/ -- Prime Therapeutics LLC (Prime) today announced that Manmohan Mahajan has been appointed as the company's chief financial officer (CFO), effective immediately.

Mahajan brings more than 20 years of global finance and leadership experience across healthcare, pharmacy and financial services organizations, and serves as a member of Chief Executive Officer Mostafa Kamal's leadership team.

"Manmohan brings deep healthcare and pharmacy experience, along with a proven ability to lead large, complex organizations through transformation and growth," said Mostafa Kamal, president and chief executive officer for Prime. "At a time when pharmacy care is becoming increasingly complex, Prime's mission-aligned model uniquely positions us to help improve affordability, simplify the experience for members and achieve better health outcomes. Manmohan's leadership and perspective will help us continue delivering on that commitment while executing our strategy with discipline and focus."

Most recently, Mahajan served as executive vice president and global CFO for Walgreens Boots Alliance, where he spent 10 years in finance leadership roles of increasing responsibility while leading large-scale transformation, capital structure work, cost discipline and organizational simplification. Prior to Walgreens, he held several senior finance roles over 13 years with GE Capital.

"I am excited to join Prime, and to be a part of a company and culture that is committed to making healthcare more affordable and accessible," Mahajan said. "I look forward to working with Mostafa and the rest of the leadership team to further position Prime as a pharmacy solutions leader, while delivering measurable, long-term value for payers and patients."

Mahajan succeeds Ken Bodmer, who earlier this year shared plans to step away from the CFO role into a part-time advisory role, and will work closely with Mahajan over the months ahead as part of the transition.

"I want to thank Ken for his significant contributions, steady leadership and enterprise partnership during an important period for Prime, and I'm pleased that we will continue to benefit from his expertise and experience in advancing our strategic priorities," said Kamal.

About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a pharmacy solutions partner that delivers savings, simplicity and support to customers and members. Prime provides care to millions of people across the country through pharmacy benefit management, specialty and medical drug management, and state government solutions. Prime creates a new standard for the industry by doing what's right through a conflict-free approach, offering a holistic specialty experience, accessing the most modern technology, and emphasizing purpose beyond profits. To learn more, visit PrimeTherapeutics.com or follow Prime on LinkedIn.

Contact:

Alex Cook

Senior Public Relations Manager

612.777.4217

[email protected]

SOURCE Prime Therapeutics LLC

Share this article

Class (B2B/B2C)
B2B
Ingest Status
Need Review
Dedupe hash
prn_302874471
Press Eligible
Yes
Press Eligible Reason
QA FAIL (need review): Target contains an unsupported factual claim: it states Mahajan held the Walgreens CFO role for 10 years, whereas the source says he spent 10 years in finance leadership roles. It also adds that Mahajan 'reports directly to the CEO,' which is not explicitly stated in the source.
Source Name
Unknown Company
Original Summary

<p>EAGAN, Minn., Sept. 10, 2026 /PRNewswire/ -- Prime Therapeutics LLC (Prime) today announced that Manmohan Mahajan has been appointed as the company's chief financial officer (CFO), effective immediately. Mahajan brings more than 20 years of global finance and leadership experience across...</p>

Original Link
Original Source
Image URL
https://mmx.prnewswire.com/media/MS1103167/Prime-Therapeutics-logo.jpg?id=OA2939165&p=facebook
Generated Article_json
{"target_audience": "b2b", "is_medical": false, "ai_generated_title": "Prime Therapeutics Names Ex-Walgreens Boots Alliance CFO Mahajan", "body_html": "<p><strong>Eagan, Minn. -- [CURRENT_DATE] --</strong> Prime Therapeutics LLC has appointed Manmohan Mahajan as chief financial officer, effective immediately, bringing more than two decades of finance leadership from Walgreens Boots Alliance and GE Capital to the pharmacy benefit manager.</p><h5>Mahajan joins Prime's leadership team after a decade at Walgreens Boots Alliance</h5><p>Mahajan most recently served as executive vice president and global CFO for Walgreens Boots Alliance, a role he held for 10 years while overseeing large-scale transformation, capital structure decisions, cost discipline and organizational simplification. Before Walgreens, he spent 13 years in senior finance roles at GE Capital.</p><h5>Mahajan succeeds Ken Bodmer as Prime restructures its finance leadership</h5><p>He replaces Ken Bodmer, who earlier in 2026 announced plans to move from the CFO position into a part-time advisory role. Bodmer will work closely with Mahajan during the transition period to support continuity in the company's financial strategy.</p><h5>Kamal cites Mahajan's healthcare and pharmacy experience for the appointment</h5><p>CEO Mostafa Kamal said Mahajan's background in leading complex organizations through transformation and growth will support Prime's push to improve affordability and simplify pharmacy care for members. Mahajan now sits on Kamal's executive leadership team and reports directly to the CEO.</p><p>Mahajan said his priority is positioning Prime as a pharmacy solutions leader while delivering measurable, long-term value for payers and patients.</p>", "meta_description": "Prime Therapeutics names Manmohan Mahajan CFO, tapping his decade at Walgreens Boots Alliance and 13 years at GE Capital to lead finance strategy.", "seo_keywords": "Prime Therapeutics, CFO appointment, Manmohan Mahajan, Walgreens Boots Alliance, pharmacy benefit management, healthcare finance leadership", "companies": ["Prime Therapeutics", "Walgreens Boots Alliance", "GE Capital"], "industries": ["Healthcare & Biotech"], "markets_regions": ["United States"], "news_type": ["executive_appointment", "general_news"], "themes": ["leadership_change", "corporate_strategy"], "products": [], "events": [], "cta_text": "Details on Prime Therapeutics' leadership transition and executive team", "learn_more": "https://PrimeTherapeutics.com", "fact_check": {"accuracy_score": 100, "legal_risk": "low", "corrections_made": [], "recommendation": "publish"}}
Content Hash (SHA-256, erste 32 hex)
861d2ac0947cea141748791aa5eb5821